ATA12192000A - Antimykotisch wirkendes arzneimittel - Google Patents

Antimykotisch wirkendes arzneimittel

Info

Publication number
ATA12192000A
ATA12192000A AT0121900A AT12192000A ATA12192000A AT A12192000 A ATA12192000 A AT A12192000A AT 0121900 A AT0121900 A AT 0121900A AT 12192000 A AT12192000 A AT 12192000A AT A12192000 A ATA12192000 A AT A12192000A
Authority
AT
Austria
Prior art keywords
antimycotic
medicinal product
medicinal
product
antimycotic medicinal
Prior art date
Application number
AT0121900A
Other languages
English (en)
Other versions
AT409084B (de
Original Assignee
Ledochowski Maximilian Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ledochowski Maximilian Dr filed Critical Ledochowski Maximilian Dr
Priority to AT0121900A priority Critical patent/AT409084B/de
Priority to PCT/AT2001/000200 priority patent/WO2002003982A1/de
Priority to AU2001265664A priority patent/AU2001265664A1/en
Publication of ATA12192000A publication Critical patent/ATA12192000A/de
Application granted granted Critical
Publication of AT409084B publication Critical patent/AT409084B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0121900A 2000-07-13 2000-07-13 Antimykotisch wirkendes arzneimittel AT409084B (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AT0121900A AT409084B (de) 2000-07-13 2000-07-13 Antimykotisch wirkendes arzneimittel
PCT/AT2001/000200 WO2002003982A1 (de) 2000-07-13 2001-06-25 Antimykotisch wirkendes arzneimittel
AU2001265664A AU2001265664A1 (en) 2000-07-13 2001-06-25 Antimycotic pharmaceutical

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0121900A AT409084B (de) 2000-07-13 2000-07-13 Antimykotisch wirkendes arzneimittel

Publications (2)

Publication Number Publication Date
ATA12192000A true ATA12192000A (de) 2001-10-15
AT409084B AT409084B (de) 2002-05-27

Family

ID=3687341

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0121900A AT409084B (de) 2000-07-13 2000-07-13 Antimykotisch wirkendes arzneimittel

Country Status (3)

Country Link
AT (1) AT409084B (de)
AU (1) AU2001265664A1 (de)
WO (1) WO2002003982A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005082054A2 (en) * 2004-02-26 2005-09-09 Sosei Co., Ltd. Combinations for the treatment of fungal infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3628545A1 (de) * 1985-09-23 1987-04-23 Hoechst Ag Arylmethylazole und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
DE3707151A1 (de) * 1987-03-06 1988-09-15 Hoechst Ag 1-(1-aryl-2-hydroxy-ethyl)-imidazole und deren salze, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung
AU2880595A (en) * 1994-07-06 1996-01-25 Bo Arne Hofmann Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
AU2880495A (en) * 1994-07-06 1996-01-25 Bo Arne Hofmann Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
US5658955A (en) * 1994-11-01 1997-08-19 Hitzig; Pietr Combined use of dopamine and serotonin agonists in the treatment of immune disorders
WO1996022085A1 (en) * 1995-01-17 1996-07-25 Pfizer Inc. The use of sertraline to treat cancer patients

Also Published As

Publication number Publication date
AU2001265664A1 (en) 2002-01-21
AT409084B (de) 2002-05-27
WO2002003982A1 (de) 2002-01-17

Similar Documents

Publication Publication Date Title
ATE318137T1 (de) Parenteral anzuwendendes bisphosphonathaltiges arzneimittel
DE60004685D1 (de) Pyrazolopyrimidine als arzneimittel
ATE311915T1 (de) Medikamentenspender
ITTO20010008A0 (it) Formulazione farmaceutica
ATE380814T1 (de) Kinaseinhibitoren als arzneimittel
NO20071303L (no) Farmasoytiske preparater
DE69908021D1 (de) Ziprasidonhaltige Arzneimittel
NO20030418D0 (no) Nytt farmasöytisk preparat
BR0212017B1 (pt) produto cosmético
NO20030627L (no) Hydrogel-drevet medikament doseringsform
NO20033556D0 (no) Farmasöytiske preparater
DK1524266T3 (da) Farmaceutisk sammensætning
EE200300416A (et) Ravimvorm
EP1049474A4 (de) Cannabimimetische lipidamide als arzneimittel
DE60203537D1 (de) 5ht1-rezeptoragonist enthaltendes arzneimittel
EP1299337A4 (de) Hydroxyphenstatin und seine promedikamente
NO20014926D0 (no) Farmasöytiske forbindelser
ITMI20001827A0 (it) Medicamento antinfiammatorio
DK1331972T3 (da) Farmaceutiske præparater
DE60105054D1 (de) Fluidproduktspender
ATE359085T1 (de) Arzneimittel enthaltend aktiviertes antithrombin iii
ATE269337T1 (de) Trizyclische delta3-pyridine als arzneimittel
ATE259233T1 (de) Lamivudin enthaltende arzneimittel
ATA12192000A (de) Antimykotisch wirkendes arzneimittel
NO991359D0 (no) Tablettdispenser

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee